The early development of embryos is not well understood. One necessary stage is the formation of the blastocyst, a collection
Continue reading »
Teens’ same-gender friendships key to later satisfaction in romantic relationships
Researchers have long known that the quality of an adult’s romantic life is closely tied to both physical and mental
Continue reading »
Pancreatic cancer cells are ‘addicted’ to key protein
Pancreatic cancer is particularly difficult to treat. The American Cancer Society estimate that up to 61 percent of people with
Continue reading »
Nationality likely a key factor in life-and-death decisions
People making decisions about life-and-death situations consider individuals’ nationalities when deciding who should be sacrificed to save others, according to
Continue reading »
Key molecule explains why bones weaken with age
Osteoporosis affects around 200 million women worldwide. One in 3 women and 1 in 5 men aged 50 and above
Continue reading »
Often-overlooked natural killer cells may be key to cancer immunotherapy
Immune checkpoint inhibitors are revolutionizing the treatment of cancer, but new research challenges the central dogma of how these drugs
Continue reading »
A molecular key for delaying the progression of multiple sclerosis is found
Multiple sclerosis (MS) is an autoimmune disease that attacks and destroys the myelin sheath that insulates nerve cells. Current treatment
Continue reading »
Thymic tuft cells play key role in preventing autoimmunity, mouse experiments show
UC San Francisco researchers were recently surprised to discover fully formed gut and skin cells in the thymus, a lemon-sized
Continue reading »
The VIPs of the nervous system—a tiny population of neurons holds a master key to the body’s clock
Travel by airplane has opened the door to experiencing different cultures and exploring natural wonders. That is, if you can
Continue reading »
Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia
SUMMIT, N.J. & CAMBRIDGE, Mass.–July 9, 2018 (BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today
Continue reading »